These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15552198)

  • 1. Bacterial contamination rate of eyedrops: comparison of a hospital and a private outpatient center in Kermanshah, Iran.
    Jalali R; Zinolabedini F; Moradi M; Dibazar N
    Insight; 2004; 29(3):12-4. PubMed ID: 15552198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bacterial contamination of eyedrops in clinical use].
    Raynaud C; Laveran H; Rigal D; Bonicel P
    J Fr Ophtalmol; 1997; 20(1):17-24. PubMed ID: 9099279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bacterial contamination of multi-dose ocular solutions. A prospective study at the Grenoble Teaching Hospital].
    Brudieu E; Duc DL; Masella JJ; Croize J; Valence B; Meylan I; Mouillon M; Franco A; Calop J
    Pathol Biol (Paris); 1999 Dec; 47(10):1065-70. PubMed ID: 10674260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial contamination of multi-use ophthalmic solutions in Kenya.
    Nentwich MM; Kollmann KH; Meshack J; Ilako DR; Schaller UC
    Br J Ophthalmol; 2007 Oct; 91(10):1265-8. PubMed ID: 17475714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of multidose vial contamination by aerobic bacteria in a major teaching hospital, Shiraz, Iran, 2006.
    Motamedifar M; Askarian M
    Am J Infect Control; 2009 Nov; 37(9):773-7. PubMed ID: 19362388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reuse of ophthalmic minims: an unacceptable cross-infection risk?
    Yap YC; Smith M; Byles D
    Eye (Lond); 2010 Aug; 24(8):1421-2. PubMed ID: 20508657
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacterial Contamination of Multi-dose Eye Drops at Ophthalmology Department, University of Gondar, Northwest Ethiopia.
    Tsegaw A; Tsegaw A; Abula T; Assefa Y
    Middle East Afr J Ophthalmol; 2017; 24(2):81-86. PubMed ID: 28936051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reuse of opthalmic Minims: an unacceptable cross-infection risk?
    Rautenbach P; Wilson A; Gouws P
    Eye (Lond); 2010 Jan; 24(1):50-2. PubMed ID: 19247391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of fungal and bacterial contaminations of patient-used ocular drops.
    Feghhi M; Mahmoudabadi AZ; Mehdinejad M
    Med Mycol; 2008 Feb; 46(1):17-21. PubMed ID: 17885954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of the contamination of eyedrops of hospital inpatients and recommendations for the changing of current practice in eyedrop dispensing.
    Stevens JD; Matheson MM
    Br J Ophthalmol; 1992 Jan; 76(1):36-8. PubMed ID: 1739689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial contamination of preservative free eye drops in multiple application containers.
    Rahman MQ; Tejwani D; Wilson JA; Butcher I; Ramaesh K
    Br J Ophthalmol; 2006 Feb; 90(2):139-41. PubMed ID: 16424520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital.
    Teuchner B; Wagner J; Bechrakis NE; Orth-Höller D; Nagl M
    Medicine (Baltimore); 2015 Feb; 94(8):e583. PubMed ID: 25715262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial contamination of multiple-dose vials: a prevalence study.
    Mattner F; Gastmeier P
    Am J Infect Control; 2004 Feb; 32(1):12-6. PubMed ID: 14755229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial agents in eyedrops].
    Sklubalová Z
    Ceska Slov Farm; 2004 May; 53(3):107-16. PubMed ID: 15218731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterility of non-preservative eye drops.
    Prabhasawat P; Chotikavanich S; Leelaporn A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S6-10. PubMed ID: 16681044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nosocomial outbreak of epidemic keratoconjunctivitis accompanying environmental contamination with adenoviruses.
    Hamada N; Gotoh K; Hara K; Iwahashi J; Imamura Y; Nakamura S; Taguchi C; Sugita M; Yamakawa R; Etoh Y; Sera N; Ishibashi T; Chijiwa K; Watanabe H
    J Hosp Infect; 2008 Mar; 68(3):262-8. PubMed ID: 18289721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal interface contamination during laser in situ keratomileusis.
    Feizi S; Jadidi K; Naderi M; Shahverdi S
    J Cataract Refract Surg; 2007 Oct; 33(10):1734-7. PubMed ID: 17889768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open drops in ophthalmology offices: expiration and contamination.
    Wessels IF; Bekendam P; Calvin WS; Zimmerman GJ
    Ophthalmic Surg Lasers; 1999; 30(7):540-6. PubMed ID: 10929977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of bacterial contamination of three multidose ophthalmic solutions.
    Betbeze CM; Stiles J; Krohne SG
    Vet Ophthalmol; 2007; 10(2):81-3. PubMed ID: 17324162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.